- Home
- SYRE vs LFST Comparison
SYRE vs LFST Comparison
Compare SYRE & LFST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SYRE | LFST |
|---|---|---|
| Founded | 2013 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical/Nursing Services |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.6B | 2.8B |
| IPO Year | 2016 | 2021 |
Fundamental Metrics
Financial Performance| Metric | SYRE | LFST |
|---|---|---|
| Price | $33.30 | $7.28 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 6 | 6 |
| Target Price | ★ $56.50 | $8.83 |
| AVG Volume (30 Days) | 795.0K | ★ 2.0M |
| Earning Date | 02-26-2026 | 02-26-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $1,367,570,000.00 |
| Revenue This Year | N/A | $15.83 |
| Revenue Next Year | N/A | $14.29 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 13.39 |
| 52 Week Low | $10.91 | $3.74 |
| 52 Week High | $35.31 | $8.30 |
Technical Indicators
Market Signals| Indicator | SYRE | LFST |
|---|---|---|
| Relative Strength Index (RSI) | 58.08 | 59.09 |
| Support Level | $30.00 | $7.09 |
| Resistance Level | $34.21 | $7.48 |
| Average True Range (ATR) | 1.83 | 0.22 |
| MACD | -0.02 | -0.02 |
| Stochastic Oscillator | 84.46 | 66.23 |
Price Performance
Historical ComparisonAbout SYRE Spyre Therapeutics Inc.
Spyre Therapeutics Inc is a biotechnology company that aims to create the next-generation of inflammatory bowel disease (IBD) products by combining antibody engineering, rational therapeutic combinations, and precision medicine approaches for patient selection. IBD is a chronic condition characterized by inflammation within the gastrointestinal tract, including two main disorders which are UC and CD. It has a single reportable segment, which is the development of biopharmaceutical products for the treatment of patients with IBD and other immune-mediated disease.
About LFST LifeStance Health Group Inc.
LifeStance Health Group Inc is a mental healthcare company that operates as a provider of outpatient mental health services, spanning psychiatric evaluations and treatment, psychological and neuropsychological testing, and individual, family and group therapy. The group y has a single operating and reportable segment of mental health services.